FI20001542A - Menetelmä septisen sokin hoitamiseksi - Google Patents

Menetelmä septisen sokin hoitamiseksi Download PDF

Info

Publication number
FI20001542A
FI20001542A FI20001542A FI20001542A FI20001542A FI 20001542 A FI20001542 A FI 20001542A FI 20001542 A FI20001542 A FI 20001542A FI 20001542 A FI20001542 A FI 20001542A FI 20001542 A FI20001542 A FI 20001542A
Authority
FI
Finland
Prior art keywords
septic shock
treating septic
treatment
treating
levosimendan
Prior art date
Application number
FI20001542A
Other languages
English (en)
Swedish (sv)
Other versions
FI20001542A0 (fi
Inventor
Anders Oldner
Michael Wanecek
Eddie Weitzberg
Anders Rudehill
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Priority to FI20001542A priority Critical patent/FI20001542A/fi
Publication of FI20001542A0 publication Critical patent/FI20001542A0/fi
Priority to DE60104693T priority patent/DE60104693T2/de
Priority to EP01951742A priority patent/EP1294380B1/en
Priority to ES01951742T priority patent/ES2225580T3/es
Priority to AU2001272598A priority patent/AU2001272598A1/en
Priority to PCT/FI2001/000614 priority patent/WO2002000220A1/en
Priority to JP2002505002A priority patent/JP4965791B2/ja
Priority to US10/312,450 priority patent/US7485642B2/en
Priority to CA002412213A priority patent/CA2412213C/en
Priority to AT01951742T priority patent/ATE272402T1/de
Publication of FI20001542A publication Critical patent/FI20001542A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treatment Of Sludge (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI20001542A 2000-06-29 2000-06-29 Menetelmä septisen sokin hoitamiseksi FI20001542A (fi)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FI20001542A FI20001542A (fi) 2000-06-29 2000-06-29 Menetelmä septisen sokin hoitamiseksi
AT01951742T ATE272402T1 (de) 2000-06-29 2001-06-28 Behandlung von septischem schock
AU2001272598A AU2001272598A1 (en) 2000-06-29 2001-06-28 A method for treating septic shock
EP01951742A EP1294380B1 (en) 2000-06-29 2001-06-28 A method for treating septic shock
ES01951742T ES2225580T3 (es) 2000-06-29 2001-06-28 Un metodo para tratar el choque septico.
DE60104693T DE60104693T2 (de) 2000-06-29 2001-06-28 Behandlung von septischem schock
PCT/FI2001/000614 WO2002000220A1 (en) 2000-06-29 2001-06-28 A method for treating septic shock
JP2002505002A JP4965791B2 (ja) 2000-06-29 2001-06-28 敗血症性ショックの治療方法
US10/312,450 US7485642B2 (en) 2000-06-29 2001-06-28 Method for treating septic shock
CA002412213A CA2412213C (en) 2000-06-29 2001-06-28 A method for treating septic shock

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20001542A FI20001542A (fi) 2000-06-29 2000-06-29 Menetelmä septisen sokin hoitamiseksi

Publications (2)

Publication Number Publication Date
FI20001542A0 FI20001542A0 (fi) 2000-06-29
FI20001542A true FI20001542A (fi) 2001-12-30

Family

ID=8558669

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20001542A FI20001542A (fi) 2000-06-29 2000-06-29 Menetelmä septisen sokin hoitamiseksi

Country Status (10)

Country Link
US (1) US7485642B2 (fi)
EP (1) EP1294380B1 (fi)
JP (1) JP4965791B2 (fi)
AT (1) ATE272402T1 (fi)
AU (1) AU2001272598A1 (fi)
CA (1) CA2412213C (fi)
DE (1) DE60104693T2 (fi)
ES (1) ES2225580T3 (fi)
FI (1) FI20001542A (fi)
WO (1) WO2002000220A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
FI981473A (fi) 1998-06-25 1999-12-26 Orion Yhtymae Oyj Menetelmä pulmonaalihypertension hoitamiseksi
GB9915179D0 (en) 1999-06-29 1999-09-01 Orion Corp A method for the treatment or prevention of coronary graft vasospasm

Also Published As

Publication number Publication date
EP1294380B1 (en) 2004-08-04
US20030158201A1 (en) 2003-08-21
CA2412213A1 (en) 2002-01-03
ATE272402T1 (de) 2004-08-15
AU2001272598A1 (en) 2002-01-08
JP4965791B2 (ja) 2012-07-04
US7485642B2 (en) 2009-02-03
JP2004501194A (ja) 2004-01-15
DE60104693D1 (de) 2004-09-09
ES2225580T3 (es) 2005-03-16
FI20001542A0 (fi) 2000-06-29
DE60104693T2 (de) 2005-08-11
CA2412213C (en) 2009-04-14
WO2002000220A1 (en) 2002-01-03
EP1294380A1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
ATE328874T1 (de) Substituieten triazoldiamin derivaten und ihre verwendung als kinase inhibitoren
CA2134972A1 (en) Anti-ischemic medicament
NZ507835A (en) Heterocyclic derivatives which inhibit factor XA
WO2001078653A3 (en) Graft rejection inhibition with ccr2 inhibitors
ATE261939T1 (de) Amidinoderivate und ihre verwendung als thrombin- inhibitoren
FI20001542A (fi) Menetelmä septisen sokin hoitamiseksi
WO1999066912A3 (en) Method of treating pulmonary hypertension
GB9915179D0 (en) A method for the treatment or prevention of coronary graft vasospasm
YU63900A (sh) Peroralne kompozicije koje kontrolisano oslobađaju levosimendan
CA2431125A1 (en) A method for treating erectile dysfunction
DE60016038D1 (de) Neue verwendung von levosimendan
WO2000053013A8 (en) Inhibition of pkc to treat permeability failure